Tuesday, April 21, 2020 9:29:58 AM
Maybe there is a pre-existing relationship with PMCB
and Prof Albert Yu
Next will come that Haikang is going to fund PMCB. No doubt with the 10% kickback royalties from PMCB, on non-existent kit sales.
Keep buying.
And Kenny has committed to SHs to notify them when it goes in- right?
A month or 2, or dozen. Been like that for the past couple of years.
For a real biotech that will be a short wait. For PMCB, that's an excuse for another couple of yrs.
Meanwhile we have the new star Professor Yu. Eat your heart out Hidalgo! You have been replaced in the hearts and minds of SHs! LOL
and Prof Albert Yu
Next will come that Haikang is going to fund PMCB. No doubt with the 10% kickback royalties from PMCB, on non-existent kit sales.
in fact I am betting on it , as I am buying more PMCB
Keep buying.
IND will be submitted , I say another month or 2
And Kenny has committed to SHs to notify them when it goes in- right?
A month or 2, or dozen. Been like that for the past couple of years.
then we may have to wait for hospital Trial sites to get back to normal
For a real biotech that will be a short wait. For PMCB, that's an excuse for another couple of yrs.
Meanwhile we have the new star Professor Yu. Eat your heart out Hidalgo! You have been replaced in the hearts and minds of SHs! LOL
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
